Ivermectin Shows Promise in Reducing Malaria Transmission in Large-Scale Trials
Large-scale trials demonstrate that ivermectin can significantly reduce malaria transmission and offers a promising complementary tool in malaria control efforts.
A groundbreaking study published in The New England Journal of Medicine reveals that administering ivermectin to entire populations significantly decreases malaria transmission rates, especially when combined with existing control strategies such as bed nets and insecticides. Conducted by the Barcelona Institute for Global Health (ISGlobal) in collaboration with other research centers, the BOHEMIA trial is the largest of its kind, involving over 20,000 participants across Kenya and Mozambique.
The trial assessed the safety and efficacy of a monthly dose of ivermectin (400 mcg/kg) given for three months at the beginning of the rainy season. In Kenya, the focus was on children aged 5–15, while in Mozambique, children under five were targeted. Results showed a 26% reduction in new malaria cases in Kenya, with ivermectin treatment being safe and well-tolerated, showing only mild side effects already known from treating neglected tropical diseases. Notably, children living farther from cluster borders or in areas with more effective drug delivery experienced greater declines.
The Mozambique trial faced logistical challenges due to Cyclone Gombe and a cholera outbreak, highlighting the importance of community engagement for success. The research also uncovered collateral benefits: reductions in skin infestations such as scabies and head lice, and fewer bed bugs in Kenya. These findings suggest that ivermectin can serve as a valuable complementary tool in malaria control, especially as insecticide resistance becomes a growing concern.
Expert opinions from the study emphasize ivermectin's potential to bolster existing strategies and contribute to eradication efforts. The WHO's vector control advisory group has reviewed the evidence and recommended further studies. With its well-known safety profile and unique mechanism of killing mosquitoes that feed on treated individuals, ivermectin offers a promising, innovative approach to combating malaria globally.
Source: https://medicalxpress.com/news/2025-07-ivermectin-lowers-malaria-infection-added.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rapid Evolution of Bird Flu Enhances Infection and Spread Among Hosts
New research highlights the rapid evolution of the bird flu virus, showing increased infectivity, broader host range, and enhanced spread across regions, mainly driven by wild bird migration and genetic reassortment.
Uncertainty Surrounds the Safety and Effectiveness of Popular Air Cleaning Devices
Most portable air cleaning devices are rarely tested on people, leaving uncertainties about their effectiveness and potential health harms. A recent review emphasizes the need for thorough real-world testing to ensure safety and efficacy.
Lower Risks of Dementia, Stroke, and Mortality Associated with GLP-1 Receptor Agonists in Type 2 Diabetes and Obesity
Recent research highlights that GLP-1 receptor agonists significantly decrease the risk of dementia, stroke, and death in individuals with type 2 diabetes and obesity, offering promising neuroprotective benefits beyond glucose management.